tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
PLX is currently covered by 1 analysts with an average price target of $4.06. This is a potential upside of $2.27 (126.82%) from yesterday's end of day stock price of $1.79.
Protalix Biotherapeutics's activity chart (see below) currently has 14 price targets and 10 ratings on display. The stock rating distribution of PLX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 209 days.
Highest price target for PLX is $12, Lowest price target is $12, average price target is $12.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 21-Nov-2025. First documented stock forecast 23-Apr-2015.
Currently out of the existing stock ratings of PLX, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$12
$10.17 (555.74%)
$10
21 days ago
(21-Nov-2025)
0/6 (0%)
$10.25 (585.71%)
Buy
$2.1
$0.27 (14.75%)
$8
8 years 1 months 23 days ago
(19-Oct-2017)
2/4 (50%)
$-5.71 (-73.11%)
418
What is PLX (Protalix Biotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PLX (Protalix Biotherapeutics) with a proven track record?
Which analyst has the current lower performing score on PLX (Protalix Biotherapeutics) with a proven track record?
Which analyst has the most public recommendations on PLX (Protalix Biotherapeutics)?
Which analyst is the currently most bullish on PLX (Protalix Biotherapeutics)?
Which analyst is the currently most reserved on PLX (Protalix Biotherapeutics)?
